Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

The transcription factor c-MYC is stabilized and activated by phosphorylation at serine 62 (S62) in breast cancer. Protein phosphatase 2A (PP2A) is a critical negative regulator of c-MYC through its ability to dephosphorylate S62. By inactivating c-MYC and other key signaling pathways, PP2A plays an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Janghorban, Mahnaz, Farrell, Amy S., Allen-Petersen, Brittany L., Pelz, Carl, Daniel, Colin J., Oddo, Jessica, Langer, Ellen M., Christensen, Dale J., Sears, Rosalie C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2014
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4078832/
https://ncbi.nlm.nih.gov/pubmed/24927563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1317630111
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak